Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
actin alpha 1, skeletal muscle | 0.540 | 0.769 | 1.1E-06 |
|
disease | 0.530 | 1.000 | 4 | 0 | 2001 | 2013 | |||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.640 | 1.000 | 1 | 1 | 2006 | 2018 | |||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.570 | 1.000 | 1 | 0 | 2006 | 2016 | |||||||||
|
potassium voltage-gated channel subfamily Q member 1 | 0.485 | 0.769 | 4.5E-08 |
|
disease | 0.520 | 1.000 | 1 | 0 | 2014 | 2016 | |||||||||
|
mitogen-activated protein kinase kinase 2 | 0.534 | 0.731 | 0.97 |
|
disease | 0.540 | 1.000 | 1 | 0 | 2007 | 2016 | |||||||||
|
checkpoint kinase 1 | 0.492 | 0.808 | 3.1E-08 |
|
disease | 0.320 | 1.000 | 0 | 0 | 2003 | 2010 | |||||||||
|
alpha-2-macroglobulin like 1 | 0.590 | 0.692 | 1.6E-34 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
alpha-2-macroglobulin like 1 | 0.590 | 0.692 | 1.6E-34 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
alpha-2-macroglobulin like 1 | 0.590 | 0.692 | 1.6E-34 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
alpha-2-macroglobulin like 1 | 0.590 | 0.692 | 1.6E-34 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
alpha-2-macroglobulin like 1 | 0.590 | 0.692 | 1.6E-34 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
catenin alpha 1 | 0.584 | 0.538 | 0.97 |
|
group | 0.300 | 0 | 0 | ||||||||||||
|
catenin alpha 1 | 0.584 | 0.538 | 0.97 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
catenin alpha 1 | 0.584 | 0.538 | 0.97 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
catenin alpha 1 | 0.584 | 0.538 | 0.97 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
catenin alpha 1 | 0.584 | 0.538 | 0.97 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
desmoplakin | 0.514 | 0.808 | 1.00 |
|
disease | 0.310 | 1.000 | 0 | 0 | 2017 | 2017 | |||||||||
|
muscle RAS oncogene homolog | 0.590 | 0.731 | 0.92 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
muscle RAS oncogene homolog | 0.590 | 0.731 | 0.92 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
muscle RAS oncogene homolog | 0.590 | 0.731 | 0.92 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
muscle RAS oncogene homolog | 0.590 | 0.731 | 0.92 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
muscle RAS oncogene homolog | 0.590 | 0.731 | 0.92 |
|
disease | 0.300 | 0 | 0 | ||||||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.310 | 1.000 | 0 | 0 | 2011 | 2011 | |||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.310 | 1.000 | 0 | 0 | 2011 | 2011 | |||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.300 | 0 | 0 |